Hematuria differential diagnosis: Difference between revisions
Line 17: | Line 17: | ||
| colspan="9" rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Clinical manifestations''' | | colspan="9" rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Clinical manifestations''' | ||
! colspan="2" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Para-clinical findings | ! colspan="2" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Para-clinical findings | ||
! | ! rowspan="5" |'''Gold standard''' | ||
|- | |- | ||
| colspan="6" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Symptoms''' | | colspan="6" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Symptoms''' | ||
Line 52: | Line 52: | ||
| style="background: #F5F5F5; padding: 5px;" | '''Biopsy:''' | | style="background: #F5F5F5; padding: 5px;" | '''Biopsy:''' | ||
IgA deposited in a diffuse granular patte-rn in the mesangium | IgA deposited in a diffuse granular patte-rn in the mesangium | ||
| | | style="background: #F5F5F5; padding: 5px;" |Biopsy | ||
* | * | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Alport syndrome|Hereditary nephritis (Alport syndrome)]] | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Alport syndrome|Hereditary nephritis (Alport syndrome)]] | ||
Line 75: | Line 74: | ||
| style="background: #F5F5F5; padding: 5px;" |'''Biopsy:''' | | style="background: #F5F5F5; padding: 5px;" |'''Biopsy:''' | ||
* Monoclonal antibodies directed against alpha-3 (IV), alpha-4 (IV), and alpha-5 (IV) chains of typ-e IV collagen | * Monoclonal antibodies directed against alpha-3 (IV), alpha-4 (IV), and alpha-5 (IV) chains of typ-e IV collagen | ||
| | | style="background: #F5F5F5; padding: 5px;" | | ||
* Genetic analysis | * Genetic analysis | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Poststreptococcal glomerulonephritis]] | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Poststreptococcal glomerulonephritis]] | ||
Line 101: | Line 99: | ||
* Immunoglobulin G and C3 in a diffuse granular pattern | * Immunoglobulin G and C3 in a diffuse granular pattern | ||
* Starr-y sky pattern | * Starr-y sky pattern | ||
| | | style="background: #F5F5F5; padding: 5px;" |Biopsy | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Focal segmental glomerulosclerosis|Focal segmental glomerular sclerosis]] | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Focal segmental glomerulosclerosis|Focal segmental glomerular sclerosis]] | ||
Line 127: | Line 124: | ||
* Segmental solidification in the perihilar region and peripheral areas, specially the tubular pole | * Segmental solidification in the perihilar region and peripheral areas, specially the tubular pole | ||
* Coarsely granular deposits -of IgM and C3 | * Coarsely granular deposits -of IgM and C3 | ||
| | | style="background: #F5F5F5; padding: 5px;" |Biopsy | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Rapidly progressive glomerulonephritis]] | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Rapidly progressive glomerulonephritis]] | ||
Line 154: | Line 150: | ||
| style="background: #F5F5F5; padding: 5px;" | Biopsy: | | style="background: #F5F5F5; padding: 5px;" | Biopsy: | ||
* Diffuse, proliferative, necrotizing glomerulonephritis with cresc-ent formation | * Diffuse, proliferative, necrotizing glomerulonephritis with cresc-ent formation | ||
| | | style="background: #F5F5F5; padding: 5px;" |Biopsy | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Lupus nephritis]] | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Lupus nephritis]] | ||
Line 177: | Line 172: | ||
| style="background: #F5F5F5; padding: 5px;" | Biopsy, | | style="background: #F5F5F5; padding: 5px;" | Biopsy, | ||
* Different pathologies, [[Lupus nephritis|CLICK HERE]] for more- information. | * Different pathologies, [[Lupus nephritis|CLICK HERE]] for more- information. | ||
| | | style="background: #F5F5F5; padding: 5px;" |Biopsy | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Fabry's disease|Fabry disease]] | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Fabry's disease|Fabry disease]] | ||
Line 194: | Line 188: | ||
* Proteinuria | * Proteinuria | ||
| style="background: #F5F5F5; padding: 5px;" | Biopsy | | style="background: #F5F5F5; padding: 5px;" | Biopsy | ||
| | | style="background: #F5F5F5; padding: 5px;" | Biopsy | ||
|- | |- | ||
! colspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Disease | ! colspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Disease | ||
Line 210: | Line 204: | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diagnosis method | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diagnosis method | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Gold standard | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Gold standard | ||
|- | |- | ||
| colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Tubulointerstitial diseases of the kidney|Tubulointerstitial diseases]] | | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Tubulointerstitial diseases of the kidney|Tubulointerstitial diseases]] | ||
Line 230: | Line 223: | ||
* [[Eosinophils]] are present, often in large numbers. | * [[Eosinophils]] are present, often in large numbers. | ||
| style="background: #F5F5F5; padding: 5px;" |Renal biopsy | | style="background: #F5F5F5; padding: 5px;" |Renal biopsy | ||
|- | |- | ||
| colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Nephrolithiasis]] | | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Nephrolithiasis]] | ||
Line 253: | Line 245: | ||
* Abdominal CT scan without contrast | * Abdominal CT scan without contrast | ||
| style="background: #F5F5F5; padding: 5px;" |Abdominal Ct scan without contrast | | style="background: #F5F5F5; padding: 5px;" |Abdominal Ct scan without contrast | ||
|- | |- | ||
| colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Reflux nephropathy|Reflux nephropathy (hydronephrosis)]] | | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Reflux nephropathy|Reflux nephropathy (hydronephrosis)]] | ||
Line 279: | Line 269: | ||
* Biopsy: Kidney scar | * Biopsy: Kidney scar | ||
| style="background: #F5F5F5; padding: 5px;" |– | | style="background: #F5F5F5; padding: 5px;" |– | ||
|- | |- | ||
| rowspan="4" style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Malignancy]] | | rowspan="4" style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Malignancy]] | ||
Line 301: | Line 289: | ||
* The histological pattern of renal cell [[carcinoma]] depends whether it is [[Papillary|papillary,]] [[chromophobe]] or [[collecting duct]] renal cell carcinoma. | * The histological pattern of renal cell [[carcinoma]] depends whether it is [[Papillary|papillary,]] [[chromophobe]] or [[collecting duct]] renal cell carcinoma. | ||
| style="background: #F5F5F5; padding: 5px;" |– | | style="background: #F5F5F5; padding: 5px;" |– | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Nephroblastoma]] ([[Wilms' tumor|Wilms tumor]]) | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Nephroblastoma]] ([[Wilms' tumor|Wilms tumor]]) | ||
Line 332: | Line 319: | ||
**[[Fibrous connective tissue|Fibrous tissue.]] | **[[Fibrous connective tissue|Fibrous tissue.]] | ||
| style="background: #F5F5F5; padding: 5px;" |Biopsy | | style="background: #F5F5F5; padding: 5px;" |Biopsy | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Bladder cancer]] | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Bladder cancer]] | ||
Line 349: | Line 335: | ||
| style="background: #F5F5F5; padding: 5px;" |Ultrasound, CT scan, Biopsy | | style="background: #F5F5F5; padding: 5px;" |Ultrasound, CT scan, Biopsy | ||
| style="background: #F5F5F5; padding: 5px;" |Biopsy | | style="background: #F5F5F5; padding: 5px;" |Biopsy | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Prostate cancer]] | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Prostate cancer]] | ||
Line 366: | Line 351: | ||
| style="background: #F5F5F5; padding: 5px;" |Ultrasound, CT scan, Biopsy | | style="background: #F5F5F5; padding: 5px;" |Ultrasound, CT scan, Biopsy | ||
| style="background: #F5F5F5; padding: 5px;" |Biopsy | | style="background: #F5F5F5; padding: 5px;" |Biopsy | ||
|- | |- | ||
! colspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Disease | ! colspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Disease | ||
Line 382: | Line 366: | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diagnosis method | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diagnosis method | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Gold standard | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Gold standard | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Familial|Familial diseases]] | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Familial|Familial diseases]] | ||
Line 422: | Line 405: | ||
* Microcysts | * Microcysts | ||
| style="background: #F5F5F5; padding: 5px;" |Ultrasound | | style="background: #F5F5F5; padding: 5px;" |Ultrasound | ||
|- | |- | ||
| rowspan="3" style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Vascular anomaly|Vascular diseases]] | | rowspan="3" style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Vascular anomaly|Vascular diseases]] | ||
Line 447: | Line 429: | ||
* Venography | * Venography | ||
| style="background: #F5F5F5; padding: 5px;" |'''Renal venography:''' Gold standard | | style="background: #F5F5F5; padding: 5px;" |'''Renal venography:''' Gold standard | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Granulomatosis with polyangiitis|Wegner's granulomatosis polyangiitis]] | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Granulomatosis with polyangiitis|Wegner's granulomatosis polyangiitis]] | ||
Line 477: | Line 458: | ||
* [[Degranulation]] of [[neutrophils]]. | * [[Degranulation]] of [[neutrophils]]. | ||
| style="background: #F5F5F5; padding: 5px;" |Biopsy | | style="background: #F5F5F5; padding: 5px;" |Biopsy | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Henoch-Schönlein purpura]] | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Henoch-Schönlein purpura]] | ||
Line 500: | Line 480: | ||
IgA deposited in a diffuse granular pattern in the mesangium | IgA deposited in a diffuse granular pattern in the mesangium | ||
| style="background: #F5F5F5; padding: 5px;" |Renal biopsy, and clinical syndrome | | style="background: #F5F5F5; padding: 5px;" |Renal biopsy, and clinical syndrome | ||
|- | |- | ||
! colspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Disease | ! colspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Disease | ||
Line 516: | Line 495: | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diagnosis method | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diagnosis method | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Gold standard | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Gold standard | ||
|- | |- | ||
| rowspan="4" style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Urinary system|Lower urinary tract diseases]] | | rowspan="4" style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Urinary system|Lower urinary tract diseases]] | ||
Line 545: | Line 523: | ||
* Biopsy to rule out cancer | * Biopsy to rule out cancer | ||
| style="background: #F5F5F5; padding: 5px;" |Biopsy | | style="background: #F5F5F5; padding: 5px;" |Biopsy | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Urolithiasis]] | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Urolithiasis]] | ||
Line 552: | Line 529: | ||
| style="background: #F5F5F5; padding: 5px;" | + | | style="background: #F5F5F5; padding: 5px;" | + | ||
| style="background: #F5F5F5; padding: 5px;" | + | | style="background: #F5F5F5; padding: 5px;" | + | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 563: | Line 539: | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Interstitial cystitis]] | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Interstitial cystitis]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 578: | Line 553: | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Radiogenic|Radiogenic cystitis]] | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Radiogenic|Radiogenic cystitis]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 594: | Line 568: | ||
| rowspan="5" style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Systemic diseases]] | | rowspan="5" style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Systemic diseases]] | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Hemophilia|Coagulopathy (hemophilia)]] | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Hemophilia|Coagulopathy (hemophilia)]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 609: | Line 582: | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Sickle cell anemia]] | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Sickle cell anemia]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 624: | Line 596: | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Abdominal aortic aneurysm]] | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Abdominal aortic aneurysm]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 639: | Line 610: | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Lymphomas]] | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Lymphomas]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 654: | Line 624: | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Multiple myeloma]] | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Multiple myeloma]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 682: | Line 651: | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diagnosis method | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diagnosis method | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Gold standard | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Gold standard | ||
|- | |- | ||
| rowspan="5" style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Infectious disease|Infectious diseases]] | | rowspan="5" style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Infectious disease|Infectious diseases]] | ||
Line 706: | Line 674: | ||
* [[Abscess|Abscesses]] may not be present | * [[Abscess|Abscesses]] may not be present | ||
| style="background: #F5F5F5; padding: 5px;" | - | | style="background: #F5F5F5; padding: 5px;" | - | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Cystitis]] | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Cystitis]] | ||
Line 730: | Line 697: | ||
* Also help to detect the presence of a [[tumor]] or a [[Stone massage|stone]]. | * Also help to detect the presence of a [[tumor]] or a [[Stone massage|stone]]. | ||
| style="background: #F5F5F5; padding: 5px;" |Urine culture | | style="background: #F5F5F5; padding: 5px;" |Urine culture | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Prostatitis]] | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Prostatitis]] | ||
Line 753: | Line 719: | ||
* Edema of the [[prostate gland]] with diffuse enlargement,. | * Edema of the [[prostate gland]] with diffuse enlargement,. | ||
| style="background: #F5F5F5; padding: 5px;" | - | | style="background: #F5F5F5; padding: 5px;" | - | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Urethritis]] | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Urethritis]] | ||
Line 774: | Line 739: | ||
* Diffuse, circumferential urothelial wall thickening and contrast-enhancement | * Diffuse, circumferential urothelial wall thickening and contrast-enhancement | ||
* Periureteric or perinephric fat stranding. | * Periureteric or perinephric fat stranding. | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
Line 786: | Line 750: | ||
| style="background: #F5F5F5; padding: 5px;" | - | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" | - | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 794: | Line 757: | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Urogenital|Urogenital trauma]] | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Urogenital|Urogenital trauma]] | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Inserted [[bladder]] or [[Ureteral disease|ureteral catheters]] | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Inserted [[bladder]] or [[Ureteral disease|ureteral catheters]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | |
Revision as of 16:59, 1 February 2019
Hematuria Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Hematuria differential diagnosis On the Web |
American Roentgen Ray Society Images of Hematuria differential diagnosis |
Risk calculators and risk factors for Hematuria differential diagnosis |
Steven C. Campbell, M.D., Ph.D. Associate Editor(s)-in-Chief: Omer Kamal, M.D.[1], Venkata Sivakrishna Kumar Pulivarthi M.B.B.S [2]
Overview
Gross hematuria(GH) must be distinguished from pigmenturia, which may be due to endogenous sources (e.g., bilirubin, myoglobin,and porphyrins), foods ingested (e.g., beets and rhubarb), drugs (e.g., phenazopyridine), and simple dehydration. This distinction can be made easily by urinalysis with microscopy. Notably, myoglobinuria and other factors can cause false-positive chemical tests for hemoglobin, so urine microscopy is required to confirm the diagnosis of hematuria. GH also must be distinguished from vaginal bleeding in women, which usually can be achieved by obtaining a careful menstrual history, collecting the specimen when the patient is not having menstrual or gynecologic bleeding, or, if necessary, obtaining a catheterized specimen. GH may also be detected by the presence of blood spotting on the undergarments of incontinent patients. After ruling out vaginal bleeding and mimics of hematuria, a urologic source must be suspected.
Differential Diagnosis
Hematuria should be differentiated from other disease which mimic hematuria especially hemoglobinuria and myoglobinuria which are dipstick positive but negative for microscopy.
Hematuria differential diagnosis
Differentiating the diseases that can cause hematuria:
Diseases | Clinical manifestations | Para-clinical findings | Gold standard | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Symptoms | Physical examina | ||||||||||||
Lab Findings | Diagnosi | ||||||||||||
Low back pain | Fever | Nausea/
Vomiting |
Urinary symptoms | Hypertension | Pitting edema | Other | |||||||
Dysuria | Frequency | Oliguria | |||||||||||
Glomerular diseases | IgA nephropathy (Berger nephropathy) | + | - | - | - | + | + | + | - | - | Biopsy:
IgA deposited in a diffuse granular patte-rn in the mesangium |
Biopsy
| |
Hereditary nephritis (Alport syndrome) | - | - | - | - | - | - | + | - |
|
Biopsy:
|
| ||
Poststreptococcal glomerulonephritis | +/- | + | - | - | + | + | + | + |
|
|
Biopsy
|
Biopsy | |
Focal segmental glomerular sclerosis | - | - | - | - | - | - | + | + |
|
|
Biopsy
|
Biopsy | |
Rapidly progressive glomerulonephritis | + | + | + | - | - | - | + | - |
|
|
Biopsy:
|
Biopsy | |
Lupus nephritis | - | + | - | - | - | - | + | + |
|
|
Biopsy,
|
Biopsy | |
Fabry disease | - | - | - | - | - | - | + | + | - |
|
Biopsy | Biopsy | |
Disease | Low back pain | Fever | Nausea/
Vomiting |
Dysuria | Frequency | Oliguria | Hypertension | Pitting edema | Other | Lab Findings | Diagnosis method | Gold standard | |
Tubulointerstitial diseases | + | + | + | – | – | – | – | – | Rash | Biopsy:
|
Renal biopsy | ||
Nephrolithiasis | + | ± | + | ± | ± | ± | – | – |
|
|
Abdominal Ct scan without contrast | ||
Reflux nephropathy (hydronephrosis) | + | + | - | - | - | - | - | + |
|
– | |||
Malignancy | Renal cell carcinoma (RCC) | - | - | - | - | - | - | ± | ± |
|
|
|
– |
Nephroblastoma (Wilms tumor) | - | - | - | - | - | - | - | - |
|
Biopsy:
|
Biopsy | ||
Bladder cancer | - | - | - | - | ± | ± | - | - | Suprapubic pain | Ultrasound, CT scan, Biopsy | Biopsy | ||
Prostate cancer | ± | - | - | - | ± | ± | - | - | - | Ultrasound, CT scan, Biopsy | Biopsy | ||
Disease | Low back pain | Fever | Nausea/
Vomiting |
Dysuria | Frequency | Oliguria | Hypertension | Pitting edema | Other | Lab Findings | Diagnosis method | Gold standard | |
Familial diseases | Polycystic kidney disease | + | - | - | - | - | - | + | + |
|
Ultrasound:
CT:
Genetic testing demonstrates: Biopsy:
|
Ultrasound | |
Vascular diseases | Renal vein thrombosis | + | + | + | - | - | - | - | - |
|
|
|
Renal venography: Gold standard |
Wegner's granulomatosis polyangiitis | - | - | - | - | - | +/- | + | + |
|
|
CT chest:
Biopsy:
|
Biopsy | |
Henoch-Schönlein purpura | - | - | - | - | - | +/- | +/- | + |
|
|
Biopsy:
IgA deposited in a diffuse granular pattern in the mesangium |
Renal biopsy, and clinical syndrome | |
Disease | Low back pain | Fever | Nausea/
Vomiting |
Dysuria | Frequency | Oliguria | Hypertension | Pitting edema | Other | Lab Findings | Diagnosis method | Gold standard | |
Lower urinary tract diseases | Benign prostatic hyperplasia | +/- | - | - | + | + | - | - | - |
|
|
|
Biopsy |
Urolithiasis | + | +/- | + | + | |||||||||
Interstitial cystitis | |||||||||||||
Radiogenic cystitis | |||||||||||||
Systemic diseases | Coagulopathy (hemophilia) | ||||||||||||
Sickle cell anemia | |||||||||||||
Abdominal aortic aneurysm | |||||||||||||
Lymphomas | |||||||||||||
Multiple myeloma | |||||||||||||
Disease | Low back pain | Fever | Nausea/
Vomiting |
Dysuria | Frequency | Oliguria | Hypertension | Pitting edema | Other | Lab Findings | Diagnosis method | Gold standard | |
Infectious diseases | Pyelonephritis | + | + | + | + | + | + | - | - |
|
CT and ultrasound: | - | |
Cystitis | - | - | - | + | + | + | - | - |
|
|
|
Urine culture | |
Prostatitis | - | + | - | + | + | + | - | - |
|
|
Ultrasound:
CT scan:
|
- | |
Urethritis | -/- | + | - | + | + | + | - | - |
|
|
CT scan:
|
||
Epididymitis | -/+ | + | + | - | - | - | - | - | |||||
Urogenital trauma | Inserted bladder or ureteral catheters |
References
- ↑ Hartman DS, Sanders RC (April 1982). "Wilms' tumor versus neuroblastoma: usefulness of ultrasound in differentiation". J Ultrasound Med. 1 (3): 117–22. PMID 6152936.
- ↑ De Campo JF (1986). "Ultrasound of Wilms' tumor". Pediatr Radiol. 16 (1): 21–4. PMID 3003660.
- ↑ Cahan LD (1985). "Failure of encephalo-duro-arterio-synangiosis procedure in moyamoya disease". Pediatr Neurosci. 12 (1): 58–62. PMID 4080660.